Lisham Ashrafioun1, Sarah Heavey2, Taraneh Canarapen3, Todd M Bishop4, Wilfred R Pigeon4. 1. Department of Psychiatry, University of Rochester Medical Center, USA; VA Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, USA. Electronic address: Lisham_ashrafioun@urmc.rochester.edu. 2. Department of Psychiatry, University of Rochester Medical Center, USA. 3. Mental Health Services, Canandaigua VA Medical Center, USA. 4. Department of Psychiatry, University of Rochester Medical Center, USA; VA Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, USA.
Abstract
BACKGROUND: Understanding reasons for prescription opioid misuse can help elucidate suicide prevention efforts. The goal of the current study is to assess associations of reasons for prescription opioid misuse subtypes and suicide-related variables. We also assessed whether prescription opioid misuse differentiates ideators from those who attempt suicide. METHODS: Using data from the 2015-2017 National Survey of Drug Use and Health (N = 45,074), prescription opioid misuse subtypes were grouped as follows: (a) Pain only, (b) Other reasons, and (c) Mixed reasons (i.e., pain and at least one other reason). Logistic regressions examined associations of misuse subtypes and past 12-month suicide-related variables (ideation, planning, attempts) relative to non-misusers. Logistic regression analyses were also conducted among the subset reporting ideation to assess whether prescription opioid misuse differentiated ideators with no attempt from ideators with an attempt. RESULTS: In adjusted models, the Pain only and the Other reasons subtypes were associated with ideation and planning, but not attempts. The Mixed reasons subtype had higher odds of suicide ideation and planning compared to those not misusing prescription opioids and the Pain only misuse subtype. The Mixed reasons subtype had higher odds of a suicide attempt only when compared to those not misusing prescription opioids. Prescription opioid misuse was also associated with suicide attempts among the subset of ideators. CONCLUSIONS: Findings indicate that people misuse prescription opioids for various reasons, and misuse subtypes are associated with past 12-month suicidality. Addressing pain and other reasons for misuse together through use of evidence-based treatments may help mitigate suicide risk. Published by Elsevier B.V.
BACKGROUND: Understanding reasons for prescription opioid misuse can help elucidate suicide prevention efforts. The goal of the current study is to assess associations of reasons for prescription opioid misuse subtypes and suicide-related variables. We also assessed whether prescription opioid misuse differentiates ideators from those who attempt suicide. METHODS: Using data from the 2015-2017 National Survey of Drug Use and Health (N = 45,074), prescription opioid misuse subtypes were grouped as follows: (a) Pain only, (b) Other reasons, and (c) Mixed reasons (i.e., pain and at least one other reason). Logistic regressions examined associations of misuse subtypes and past 12-month suicide-related variables (ideation, planning, attempts) relative to non-misusers. Logistic regression analyses were also conducted among the subset reporting ideation to assess whether prescription opioid misuse differentiated ideators with no attempt from ideators with an attempt. RESULTS: In adjusted models, the Pain only and the Other reasons subtypes were associated with ideation and planning, but not attempts. The Mixed reasons subtype had higher odds of suicide ideation and planning compared to those not misusing prescription opioids and the Pain only misuse subtype. The Mixed reasons subtype had higher odds of a suicide attempt only when compared to those not misusing prescription opioids. Prescription opioid misuse was also associated with suicide attempts among the subset of ideators. CONCLUSIONS: Findings indicate that people misuse prescription opioids for various reasons, and misuse subtypes are associated with past 12-month suicidality. Addressing pain and other reasons for misuse together through use of evidence-based treatments may help mitigate suicide risk. Published by Elsevier B.V.
Authors: Mark A Ilgen; Kara Zivin; Karen L Austin; Amy S B Bohnert; Ewa K Czyz; Marcia Valenstein; Amy M Kilbourne Journal: Suicide Life Threat Behav Date: 2010-12
Authors: Mark A Ilgen; Felicia Kleinberg; Rosalinda V Ignacio; Amy S B Bohnert; Marcia Valenstein; John F McCarthy; Frederic C Blow; Ira R Katz Journal: JAMA Psychiatry Date: 2013-07 Impact factor: 21.596
Authors: Mark A Ilgen; Amy S B Bohnert; Dara Ganoczy; Matthew J Bair; John F McCarthy; Frederic C Blow Journal: Pain Date: 2016-05 Impact factor: 7.926
Authors: Chongliang Luo; Kun Chen; Riddhi Doshi; Nathaniel Rickles; Yong Chen; Harold Schwartz; Robert H Aseltine Journal: PLoS One Date: 2022-06-30 Impact factor: 3.752
Authors: Joanna M Streck; Maria A Parker; Benjamin Bearnot; Kelly Kalagher; Stacey C Sigmon; Renee D Goodwin; Andrea H Weinberger Journal: Subst Use Misuse Date: 2022-03-02 Impact factor: 2.362
Authors: Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall Journal: Drug Alcohol Rev Date: 2022-04-18
Authors: Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams Journal: BMC Public Health Date: 2020-11-18 Impact factor: 3.295